Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals
NCT ID: NCT01706224
Last Updated: 2014-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
757 participants
OBSERVATIONAL
2012-11-30
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Healthcare Workers Knowledge Regarding Their Vaccination Status at Melun Hospital
NCT06650722
French Linguistic and Metric Validations of Parent-proxy QOL Chronic Cough Specific Questionnaire (PC-QOL)
NCT01865422
Prevalence of Long COVID-19 in the Canary Islands
NCT05228691
COVID-19 Testing and Vaccination Among Spanish Speakers
NCT05302908
Risk Level of Suffering From Traffic Injury in Primary Health Care: LESIONAT Project
NCT00778440
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Subjects in this group will be all physicians actively working at hospital centres in Spain.
Blood sample
Samples will be tested to determine the presence of anti-pertussis antibodies.
Data collection
Electronic Case Report Forms (eCRF)
Data collection
Questionnaires, active questioning.
Group B
Subjects in this group will be all nurses actively working at hospital centres in Spain.
Blood sample
Samples will be tested to determine the presence of anti-pertussis antibodies.
Data collection
Electronic Case Report Forms (eCRF)
Data collection
Questionnaires, active questioning.
Group C
Subjects in this group will be all ancillary nursing professionals actively working at hospital centres in Spain.
Blood sample
Samples will be tested to determine the presence of anti-pertussis antibodies.
Data collection
Electronic Case Report Forms (eCRF)
Data collection
Questionnaires, active questioning.
Group D
Subjects in this group will be all midwives actively working at hospital centres in Spain.
Blood sample
Samples will be tested to determine the presence of anti-pertussis antibodies.
Data collection
Electronic Case Report Forms (eCRF)
Data collection
Questionnaires, active questioning.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood sample
Samples will be tested to determine the presence of anti-pertussis antibodies.
Data collection
Electronic Case Report Forms (eCRF)
Data collection
Questionnaires, active questioning.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects who the investigator believes that they can and will comply with the requirements of the protocol.
* Male and female healthcare professionals aged ≥18 years from selected hospitals.
* Healthcare professionals in frequent contact with patients in the hospitals.
* Agreeing for collection of a blood sample for the study.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GlaxoSmithKline
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
GSK Clinical Trials
Role: STUDY_DIRECTOR
GlaxoSmithKline
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GSK Investigational Site
A Coruña, , Spain
GSK Investigational Site
L'Hospitalet de Llobregat, , Spain
GSK Investigational Site
Majadahonda, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rodriguez de la Pinta ML, Castro Lareo MI, Ramon Torrell JM, Garcia de Lomas J, Devadiga R, Reyes J, McCoig C, Tafalla M, Garcia-Corbeira P. Seroprevalence of pertussis amongst healthcare professionals in Spain. Vaccine. 2016 Feb 17;34(8):1109-14. doi: 10.1016/j.vaccine.2015.12.036. Epub 2015 Dec 22.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
115539
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.